DocDollars

Recordati_rare_diseases_inc.

NJ · United States · Reporting entity ID 100000011082

Total reported 2019–2025
$7.92M
#568 of 2,960 reporting companies — 0% of all reported industry payments
$2.90M in general payments across 24,098 records, plus $5.01M in research funding across 1,130 records.

How it breaks down

General payments $2,900,612
Research funding $5,014,727

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Recordati_rare_diseases_inc. reported $7.92M to US doctors and teaching hospitals from 2019 to 2025, ranking #568 of 2,960 reporting companies. 63% of that was research funding and 37% general payments such as consulting, speaking, food and travel. 24,098 general payment records and 1,130 research records were filed.

Common questions about Recordati_rare_diseases_inc.

How much has Recordati_rare_diseases_inc. paid US doctors?

Recordati_rare_diseases_inc. reported $7,915,339 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,900,612 in general payments, $5,014,727 in research funding.

How does Recordati_rare_diseases_inc. rank among drug and device companies?

It ranks #568 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Recordati_rare_diseases_inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.